respiratori
syncyti
viru
rsv
lead
caus
lower
respiratori
tract
infect
bronchiol
bronchopneumonia
well
hospit
children
age
year
rsv
infect
led
intermedi
intens
care
admiss
approxim
annual
birth
cohort
switzerland
nation
registri
franc
young
children
hospit
bronchiol
pediatr
intens
care
unit
picu
review
seventysix
percent
rsvposit
onethird
children
requir
noninvas
ventil
andor
mechan
ventil
six
infant
die
singlecent
studi
hong
kong
found
rsvrelat
hospit
requir
picu
support
account
annual
picu
admiss
rsv
exceed
influenza
parainfluenza
respiratori
virus
common
viral
pathogen
picu
region
hospit
hong
kong
infant
underli
cardiopulmonari
compromis
surgic
congenit
cardiac
diseas
infant
born
prematur
chronic
lung
diseas
consid
suscept
rsv
infect
result
increas
mortal
morbid
although
rsv
vaccin
avail
two
product
approv
passiv
immun
rsv
infect
rsv
immunoglobulin
rsvigiv
prepar
donor
possess
high
serum
titer
rsvneutral
antibodi
palivizumab
human
monoclon
antibodi
fusion
protein
rsv
effect
treatment
expens
usual
given
atrisk
infant
winter
month
rsv
infect
preval
howev
season
may
pose
problem
subtrop
tropic
climat
among
asian
citi
lee
et
al
report
biennial
pattern
rsvrelat
hospit
taiwan
wherea
retrospect
studi
rsv
case
picu
hong
kong
identifi
definit
season
picu
studi
suggest
younger
age
bacteri
coinfect
histori
chronic
lung
diseas
acyanot
heart
diseas
neurodevelopment
condit
eg
mental
retard
cerebr
palsi
neuromuscular
diseas
risk
factor
sever
rsv
infect
medic
cost
manag
rsvinfect
children
underli
diseas
high
region
thu
prophylact
measur
rsv
potenti
costsav
nonetheless
two
option
rsv
prophylaxi
yet
introduc
among
public
hospit
hong
kong
mainli
due
unavail
data
regard
costeffect
southern
chines
children
despit
local
hospit
author
approv
subsid
palivizumab
prophylaxi
highrisk
group
aim
studi
describ
featur
rsvposit
children
requir
picu
admiss
well
identifi
factor
associ
mortal
durat
picu
stay
hong
kong
introduct
rsv
prophylaxi
region
hong
kong
popul
million
peopl
million
year
age
http
dual
public
privat
system
pediatr
inpati
servic
total
ten
public
ten
privat
hospit
dedic
picu
avail
eight
public
hospit
design
hospit
studi
admit
sick
children
hong
kong
differ
picu
differ
admiss
polici
upper
age
limit
rang
year
old
criteria
picu
admiss
includ
cardiopulmonari
insufficiencyfailur
neurolog
deterior
concern
emerg
care
andor
gener
pediatr
staff
territorywid
retrospect
review
collect
inpati
data
period
januari
june
rsv
concern
group
form
hong
kong
societi
paediatr
respirolog
hkspr
local
profession
organ
pediatr
pulmonologist
initi
studi
two
three
coordin
eight
picu
total
bed
particip
data
retriev
total
number
rsvposit
patient
age
year
particip
hospit
review
period
retriev
hospit
microbiolog
databas
rsvassoci
picu
admiss
identifi
computer
audit
system
picu
databas
particip
depart
respect
data
one
hospit
previous
report
case
record
rsvposit
children
hospit
picu
studi
period
review
rsv
detect
use
direct
immunofluoresc
test
respiratori
sampl
nasopharyng
aspir
tracheal
aspir
bronchoalveolar
lavag
andor
viral
cultur
result
bacteri
cultur
respiratori
specimen
urin
mucou
membran
cerebrospin
fluid
blood
also
record
coordin
particip
picu
record
patient
demograph
clinic
data
anonym
use
common
data
collect
form
ethic
approv
multicent
studi
obtain
joint
chines
univers
hong
territori
east
cluster
ntec
clinic
research
ethic
committe
crec
data
express
number
percentag
median
interquartil
rang
iqr
appropri
relationship
mortal
clinic
laboratori
variabl
analyz
fisher
exact
test
categor
variabl
utest
numer
variabl
relationship
fatal
factor
suggest
signific
univari
analys
p
analyz
logist
regress
adjust
age
hospit
ident
covari
associ
length
picu
admiss
possibl
person
clinic
factor
evalu
utest
confirm
stepwis
linear
regress
comparison
made
onetail
risk
factor
known
associ
rsv
sever
twotail
variabl
use
spss
spss
inc
chicago
il
pvalu
consid
statist
signific
total
rsvposit
pediatr
case
identifi
studi
period
tabl
describ
distribut
among
eight
picu
one
hundr
eighteen
rsvassoci
picu
admiss
eight
particip
hospit
identifi
children
includ
one
patient
admit
twice
march
octob
case
confirm
review
hospit
microbiolog
databas
sixtyf
patient
year
age
respect
fourteen
admiss
involv
infant
day
age
chronic
lung
diseas
defin
infant
oxygendepend
day
life
cyanot
heart
diseas
patient
includ
tetralog
fallot
pulmonari
atresia
transposit
great
arteri
interrupt
aortic
arch
total
anomal
pulmonari
venou
drainag
acyanot
heart
diseas
includ
atrial
sepal
defect
ventricular
septal
defect
endocardi
cushion
defect
patent
ductu
arteriosu
coarctat
aorta
concern
clinic
featur
picu
admiss
wheez
cough
dyspnea
rhinorrhea
fever
found
patient
respect
vomit
report
patient
diarrhea
four
patient
presenc
featur
differ
death
surviv
case
p
figur
describ
season
pattern
rsvassoci
picu
admiss
tend
higher
winter
month
octob
march
bacteri
coinfect
present
episod
picu
admiss
tabl
provid
detail
bacteri
isol
eight
patient
die
median
iqr
age
year
figur
describ
underli
diseas
death
case
two
age
year
old
mortal
differ
among
eight
hospit
p
tabl
summar
distribut
clinic
diseaserel
factor
death
surviv
patient
prior
sick
contact
presenc
older
sibl
neurodevelopment
condit
chromosom
genet
diseas
bacteri
coinfect
associ
rsvassoci
mortal
although
none
remain
signific
follow
multivari
logist
regress
analysi
observ
trend
mortal
associ
prior
sick
contact
odd
ratio
confid
interv
p
tabl
illustr
relationship
durat
picu
admiss
differ
person
clinic
factor
number
factor
individu
associ
durat
picu
admiss
nonetheless
regress
analys
reveal
presenc
chronic
lung
diseas
signific
factor
durat
picu
admiss
p
first
surveil
studi
rsvassoci
picu
admiss
chines
popul
total
picu
admiss
identifi
among
rsvposit
pediatr
case
eight
govern
hospit
appar
winter
season
picu
admiss
hong
kong
eight
patient
die
factor
associ
mortal
prior
sick
contact
presenc
older
sibl
neurodevelopment
condit
chromosom
genet
diseas
bacteri
coinfect
studi
identifi
chronic
lung
diseas
risk
factor
durat
picu
admiss
eight
sick
rsvinfect
patient
die
mortal
rate
similar
publish
data
uk
lower
spain
japan
prior
sick
contact
might
risk
factor
rsvassoci
mortal
among
children
requir
picu
admiss
nonetheless
retrospect
natur
studi
allow
us
distinguish
whether
patient
acquir
rsv
hospit
household
institut
member
present
territorywid
studi
presenc
convent
risk
factor
sever
rsv
infect
histori
prematur
chronic
lung
diseas
airway
abnorm
congenit
heart
diseas
neurodevelopment
condit
associ
rsvassoci
mortal
hong
kong
children
purcel
fergi
report
young
age
week
histori
prematur
congenit
heart
diseas
neurolog
diseas
risk
factor
sever
rsv
infect
twothird
patient
three
risk
factor
admit
picu
nearli
half
children
requir
mechan
ventil
taiwanes
studi
found
underli
diseas
includ
congenit
heart
chronic
lung
diseas
neurolog
disord
risk
factor
endotrach
intub
zhang
et
al
report
recent
prospect
studi
chines
children
hospit
communityacquir
pneumonia
fatal
associ
presenc
congenit
heart
diseas
trisomi
immunodefici
durat
picu
stay
import
outcom
indic
sever
rsv
infect
chronic
lung
diseas
risk
factor
longer
rsvassoci
picu
admiss
hong
kong
found
anoth
picu
studi
rsvinfect
infant
younger
year
old
risk
factor
report
studi
includ
congenit
heart
diseas
airway
abnorm
noncardiac
congenit
malform
purcel
fergi
identifi
retrospect
chart
review
patient
discharg
diagnosi
rsv
lower
respiratori
tract
infect
histori
prematur
congenit
heart
diseas
neurolog
diseas
risk
factor
longer
hospit
stay
anoth
studi
male
sex
lower
bodi
weight
higher
viral
load
day
independ
predictor
longer
durat
hospit
american
children
howev
author
report
data
specif
rsvassoci
picu
stay
devincenzo
et
al
prospect
studi
previous
healthi
natur
rsvinfect
children
report
congenit
anomali
lower
weight
admiss
higher
nasal
rsv
load
associ
longer
hospit
respiratori
failur
requir
picu
admiss
result
cast
doubt
case
select
rsv
prevent
program
initi
random
doubleblind
placebocontrol
trial
palivizumab
prophylaxi
result
lower
rate
shorter
durat
rsvrelat
hospit
less
picu
admiss
among
children
prematur
week
bronchopulmonari
dysplasia
metaanalysi
suggest
prophylact
administr
palivizumab
rsvigiv
reduc
rsvrelat
hospit
picu
admiss
american
academi
pediatr
aap
guidelin
recommend
target
approach
rsv
prophylaxi
base
risk
factor
prematur
well
chronic
lung
congenit
heart
diseas
guidelin
set
reduc
rsvrelat
hospit
instead
seriou
outcom
mortal
picu
admiss
associ
rsv
infect
major
rsvinfect
children
admit
picu
underli
medic
ill
picu
admiss
would
qualifi
rsv
prophylaxi
accord
canadian
guidelin
number
studi
yield
similar
find
among
children
differ
western
countri
besid
identifi
chronic
lung
diseas
independ
risk
factor
longer
picu
stay
support
import
includ
medic
condit
relev
guidelin
nonetheless
lack
signific
associ
seriou
rsv
outcom
known
risk
factor
prematur
congenit
heart
diseas
challeng
valid
risk
stratif
approach
addit
rsv
prophylaxi
administ
infant
two
eight
death
case
year
age
lastli
nationwid
surveil
rsv
infect
german
pediatr
hospit
reveal
patient
neuromuscular
impair
much
higher
risk
picu
admiss
mechan
ventil
mortal
data
also
suggest
neurodevelopment
condit
risk
factor
rsvassoci
mortal
although
associ
confirm
follow
multivari
analysi
overal
observ
strongli
impli
decis
algorithm
rsv
prophylaxi
restrict
highrisk
patient
defin
prematur
premorbid
cardiopulmonari
diseas
regard
time
start
rsv
prophylaxi
american
guidelin
recommend
initi
palivizumab
peak
rsv
season
novemb
march
temper
climat
north
america
substanti
variat
time
commun
outbreak
rsv
diseas
year
year
exist
within
commun
year
even
region
overal
pattern
rsv
outbreak
usual
begin
novemb
decemb
peak
januari
februari
end
end
march
time
april
rsvassoci
picu
admiss
hong
kong
fig
appear
follow
similar
season
pattern
nonetheless
rsv
season
pattern
vari
may
occur
throughout
year
equatori
countri
among
asian
countri
season
peak
observ
rsv
malaysia
korea
rsv
detect
frequent
fall
winter
continu
lower
level
throughout
year
india
wherea
rsv
infect
start
increas
earli
winter
declin
spring
japan
inconsist
data
rsv
season
asian
countri
previou
singlecent
picu
studi
rsv
case
hong
kong
fail
identifi
definit
season
wherea
taiwanes
studi
found
biennial
pattern
rsvrelat
hospit
peak
spring
fall
studi
number
limit
firstli
retrospect
studi
found
bacteria
blood
tracheal
aspir
episod
picu
admiss
bacteri
coinfect
present
three
eight
death
case
tabl
two
recent
studi
asia
also
report
bacteri
coinfect
associ
sever
rsv
infect
presenc
bacteria
tracheal
aspir
might
indic
true
infect
colon
infect
biomark
peripher
leucocyt
count
lactat
dehydrogenas
creactiv
protein
associ
sever
rsv
infect
record
case
note
patient
territorywid
surveil
sever
rsv
infect
reli
retrospect
collect
patient
data
studi
thu
liabl
recal
sampl
bias
although
coordin
tri
best
identifi
elig
picu
case
differ
databas
could
exclud
possibl
miss
patient
eight
particip
unit
besid
multicent
studi
evalu
relationship
rsvassoci
mortal
rsv
viral
load
genotyp
hospit
archiv
respiratori
sampl
rsv
isol
futur
research
purpos
addit
group
well
mani
other
report
number
emerg
respiratori
virus
human
coronavirus
metapneumoviru
rhinovirus
import
caus
sever
respiratori
tract
infect
young
children
patient
coinfect
rsv
anoth
viru
might
sever
diseas
present
studi
investig
possibl
coinfect
picu
patient
conclus
hong
kong
children
hospit
rsv
infect
need
picu
admiss
major
admiss
occur
winter
month
prior
sick
contact
appear
risk
factor
rsvassoci
mortal
wherea
chronic
lung
diseas
major
determin
durat
picu
stay
